ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

Chest X-Rays In BRCA Carriers May Increase Cancer Risk

July 28, 2006

Hammer Blast GAO Report As ”Gobblygook”

June 12, 1987

No Cancer Letter for Two Weeks

August 13, 1993

NCI Looking At CCOP Budgets To Determine How Many Will Be Funded; Some Top Scorers Identified

March 13, 1987

Committee Unblinds Phase III Zytiga Study

March 30, 2012

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987